Alaphatic pyrazinoylguanidine sodium channel blockers

Details Alaphatic pyrazinoylguanidine sodium channel blockers Alaphatic pyrazinoylguanidine sodium channel blockers

2008-05-20

2008-05-20

Tucker, Zachary C (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S407000

Reexamination Certificate

active

07375107

ABSTRACT:
The present invention provides compound represented by formula (I):where the structural variables are defined herein. The compounds function as sodium channel blockers and may be used to treat a variety of respiratory conditions.

REFERENCES:
patent: 6858614 (2005-02-01), Johnson
patent: 6858615 (2005-02-01), Johnson
patent: 6903105 (2005-06-01), Johnson
patent: 2003/0195160 (2003-10-01), Johnson
patent: 2003/0199456 (2003-10-01), Johnson
patent: 2004/0162296 (2004-08-01), Johnson
patent: 2004/0198744 (2004-10-01), Johnson
patent: 2004/0198745 (2004-10-01), Johnson
patent: 2004/0198746 (2004-10-01), Johnson
patent: 2004/0198747 (2004-10-01), Johnson
patent: 2004/0198748 (2004-10-01), Johnson
patent: 2004/0198749 (2004-10-01), Johnson
patent: 2004/0204424 (2004-10-01), Johnson
patent: 2004/0204425 (2004-10-01), Johnson
patent: 2004/0229884 (2004-11-01), Johnson
patent: 2005/0059676 (2005-03-01), Johnson
patent: 2005/0080091 (2005-04-01), Johnson et al.
patent: 2005/0080093 (2005-04-01), Johnson et al.
patent: 2005/0090505 (2005-04-01), Johnson et al.
patent: 2005/0113388 (2005-05-01), Johnson
patent: 2005/0113389 (2005-05-01), Johnson
patent: 2005/0113390 (2005-05-01), Johnson
patent: 2005/0228182 (2005-10-01), Johnson
patent: 2005/0234072 (2005-10-01), Johnson
Kellerman, D. “P2Y2 Receptor Agonists” CHEST, vol. 121(5), pp. 201S-205S (May 2002 Supplement).
Thomas R. Kleyman, et al., “New amiloride analogue as hapten to raise anti-amiloride antibodies”, American Journal of Physiology, vol. 250, (1, Pt.1), 1986, pp. C165-C170.

Affiliated with

Also associated with

Rating

Alaphatic pyrazinoylguanidine sodium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alaphatic pyrazinoylguanidine sodium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alaphatic pyrazinoylguanidine sodium channel blockers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2763245